148 related articles for article (PubMed ID: 31930492)
1. The meninges enhance leukaemia survival in cerebral spinal fluid.
Basile P; Jonart LM; Ebadi M; Johnson K; Kerfeld M; Gordon PM
Br J Haematol; 2020 May; 189(3):513-517. PubMed ID: 31930492
[TBL] [Abstract][Full Text] [Related]
2. CXCR4 antagonists disrupt leukaemia-meningeal cell adhesion and attenuate chemoresistance.
Jonart LM; Ostergaard J; Brooks A; Fitzpatrick G; Chen L; Gordon PM
Br J Haematol; 2023 May; 201(3):459-469. PubMed ID: 36535585
[TBL] [Abstract][Full Text] [Related]
3. Cleaved L-selectin concentrations in meningeal leukaemia.
Stucki A; Cordey AS; Monai N; de Flaugergues JC; Schapira M; Spertini O
Lancet; 1995 Feb; 345(8945):286-9. PubMed ID: 7530792
[TBL] [Abstract][Full Text] [Related]
4. The choroid plexus stroma constitutes a sanctuary for paediatric B-cell precursor acute lymphoblastic leukaemia in the central nervous system.
Fernández-Sevilla LM; Valencia J; Flores-Villalobos MA; Gonzalez-Murillo Á; Sacedón R; Jiménez E; Ramírez M; Varas A; Vicente Á
J Pathol; 2020 Oct; 252(2):189-200. PubMed ID: 32686161
[TBL] [Abstract][Full Text] [Related]
5. [Neuroleukemia in adults].
Beslać-Bumbasirević Lj; Bosković D; Tomin D; Colović M; Kovacević M; Bumbasirević V
Srp Arh Celok Lek; 1996; 124(3-4):82-6. PubMed ID: 9102825
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the initial cerebro-spinal fluid (CSF) involvement of children with acute lymphoblastic leukaemia (ALL) treated without cranial irradiation: results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group study 58881.
Sirvent N; Suciu S; Rialland X; Millot F; Benoit Y; Plantaz D; Ferster A; Robert A; Lutz P; Nelken B; Plouvier E; Norton L; Bertrand Y; Otten J
Eur J Cancer; 2011 Jan; 47(2):239-47. PubMed ID: 21095115
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia.
Henriksen LT; Nersting J; Raja RA; Frandsen TL; Rosthøj S; Schrøder H; Albertsen BK;
Br J Haematol; 2014 Jul; 166(2):213-20. PubMed ID: 24702187
[TBL] [Abstract][Full Text] [Related]
8. Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia.
Miketova P; Kaemingk K; Hockenberry M; Pasvogel A; Hutter J; Krull K; Moore IM
Biol Res Nurs; 2005 Jan; 6(3):187-95. PubMed ID: 15583359
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid neopterin levels in children with central nervous system leukemia.
Millot F; Dhondt JL; Mazingue F; Mechinaud F; Auget JL; Bauters F; Harousseau JL
Leuk Lymphoma; 1993 Mar; 9(4-5):351-6. PubMed ID: 8348070
[TBL] [Abstract][Full Text] [Related]
10. Advances in understanding the pathogenesis of CNS acute lymphoblastic leukaemia and potential for therapy.
Frishman-Levy L; Izraeli S
Br J Haematol; 2017 Jan; 176(2):157-167. PubMed ID: 27766623
[TBL] [Abstract][Full Text] [Related]
11. Meningeosis leukaemica in adult acute lymphoblastic leukaemia.
Gökbuget N; Hoelzer D
J Neurooncol; 1998; 38(2-3):167-80. PubMed ID: 9696368
[TBL] [Abstract][Full Text] [Related]
12. CD99 antibody disrupts T-cell acute lymphoblastic leukemia adhesion to meningeal cells and attenuates chemoresistance.
Ebadi M; Jonart LM; Ostergaard J; Gordon PM
Sci Rep; 2021 Dec; 11(1):24374. PubMed ID: 34934147
[TBL] [Abstract][Full Text] [Related]
13. No evidence for routine cerebrospinal fluid cytology in detecting asymptomatic central nervous system relapse in children with acute lymphoblastic leukaemia: 20 years' experience of a UK primary treatment centre.
Manley S; Keenan R; Campbell H; Caswell M; Pizer B
Br J Haematol; 2014 Feb; 164(3):462-4. PubMed ID: 24422728
[No Abstract] [Full Text] [Related]
14. Flow cytometry and the study of central nervous disease in patients with acute leukaemia.
Subirá D; Castañón S; Román A; Aceituno E; Jiménez-Garófano C; Jiménez A; García R; Bernácer M
Br J Haematol; 2001 Feb; 112(2):381-4. PubMed ID: 11167834
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor.
Münch V; Trentin L; Herzig J; Demir S; Seyfried F; Kraus JM; Kestler HA; Köhler R; Barth TFE; Te Kronnie G; Debatin KM; Meyer LH
Blood; 2017 Aug; 130(5):643-654. PubMed ID: 28550041
[TBL] [Abstract][Full Text] [Related]
16. The risk of traumatic lumbar punctures in children with acute lymphoblastic leukaemia.
Shaikh F; Voicu L; Tole S; To T; Doria AS; Sung L; Alexander S
Eur J Cancer; 2014 May; 50(8):1482-9. PubMed ID: 24656342
[TBL] [Abstract][Full Text] [Related]
17. Neuroimmunitary profile estimation in cerebrospinal fluid and its importance in childhood acute lymphoblastic leukaemia.
Crivii SM; Neamtu S; Bocsan G
Arch Geschwulstforsch; 1989; 59(3):199-204. PubMed ID: 2757478
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of acute central nervous system symptoms during the treatment of childhood acute lymphoblastic leukaemia.
Banerjee J; Niinimäki R; Lähteenmäki P; Hed Myrberg I; Arola M; Riikonen P; Lönnqvist T; Palomäki M; Ranta S; Harila-Saari A; Taskinen M
Pediatr Blood Cancer; 2020 Feb; 67(2):e27999. PubMed ID: 31674724
[TBL] [Abstract][Full Text] [Related]
19. Disrupting the leukemia niche in the central nervous system attenuates leukemia chemoresistance.
Jonart LM; Ebadi M; Basile P; Johnson K; Makori J; Gordon PM
Haematologica; 2020 Aug; 105(8):2130-2140. PubMed ID: 31624109
[TBL] [Abstract][Full Text] [Related]
20. Identification of leukemic cells in the cerebrospinal fluid from children with acute lymphoblastic leukemia: advances and dilemmas.
Lauer SJ; Kirchner PA; Camitta BM
Am J Pediatr Hematol Oncol; 1989; 11(1):64-73. PubMed ID: 2653078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
